CORC

在结果中检索

CORC

浏览/检索结果: 共35条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced Non-Small Cell Lung Cancer: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
Journal of Thoracic Oncology, 2019
作者:  Yi-Long Wu;  Shun Lu;  Ying Cheng;  Caicun Zhou;  Jie Wang
收藏  |  浏览/下载：15/0  |  提交时间：2019/02/25
Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer 期刊论文
Lung Cancer, 2019, 卷号: Vol.127, 页码: 1-5
作者:  Ya-Lan Wu;  Qian Zhao;  Lei Deng;  Yan Zhang;  Xiao-Juan Zhou
收藏  |  浏览/下载：19/0  |  提交时间：2019/02/25
Progression of central nervous system metastases in advanced non-small cell lung cancer patients effectively treated with first-generation EGFR-TKI 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: Vol.13 No.4, 页码: S109-S110
作者:  Yu, M;  Zhao, Q;  Li, Y;  Zhang, S;  Zhou, X
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: Vol.36 No.12, 页码: 1207
作者:  Lu, S;  Chang, JH;  Liu, XQ;  Shi, JH;  Lu, Y
收藏  |  浏览/下载：11/0  |  提交时间：2019/02/25
Effect of prostaglandin E1 in patients with advanced lung cancer treated with chemotherapy 期刊论文
International Journal of Clinical and Experimental Medicine, 2018, 卷号: Vol.11 No.3, 页码: 2285-2291
作者:  Ren, HX;  Tian, LT;  Zhang, L;  Yang, B;  Li, L
收藏  |  浏览/下载：3/0  |  提交时间：2019/02/25
Randomized, double-blind, placebo-controlled, multicenter Phase II study of fruquintinib after two prior chemotherapy regimens in Chinese patients with advanced nonsquamous non-small-cell lung cancer 期刊论文
Journal of Clinical Oncology, 2018, 卷号: Vol.36 No.12, 页码: 1207-1217
作者:  Lu, S.;  Chang, J.;  Liu, X.;  Shi, J.;  Lu, Y.
收藏  |  浏览/下载：3/0  |  提交时间：2019/02/25
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial. 期刊论文
OncoTargets and therapy, 2018, 卷号: Vol.11, 页码: 8575-8587
作者:  Wu Yi-Long;  Xu Chong-Rui;  Hu Cheng-Ping;  Feng Jifeng;  Lu Shun
收藏  |  浏览/下载：11/0  |  提交时间：2019/02/25
Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor 期刊论文
Cancer Biotherapy and Radiopharmaceuticals, 2018, 卷号: Vol.33 No.10, 页码: 421-426
作者:  Min Yu;  Qian Zhao;  Yanying Li;  Shuang Zhang;  Yong Xu
收藏  |  浏览/下载：7/0  |  提交时间：2019/02/25
Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor 期刊论文
Cancer Biotherapy and Radiopharmaceuticals, 2018, 卷号: Vol.33 No.10, 页码: 421-426
作者:  Min Yu;  Qian Zhao;  Yanying Li;  Shuang Zhang;  Yong Xu
收藏  |  浏览/下载：5/0  |  提交时间：2019/02/25
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: A multicentre, randomised phase II trial 期刊论文
British Journal of Cancer, 2018, 卷号: Vol.118 No.5, 页码: 654-661
作者:  Han, B.;  Li, K.;  Zhao, Y.;  Li, B.;  Cheng, Y.
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace